Genome-wide association (GWA) studies, as a prototype of large-scale OMICs studies, have
advanced our understanding of the genetic basis of many common diseases. With respect to …

The achievement of genome-wide association studies (GWAS) has rapidly progressed our
understanding of the etiology of coronary artery disease (CAD). It unlocks new strategies to …

The sequencing of the human genome1 and the subsequent completion of the human
haplotype mapping (HapMap) project2 have led to unparalleled research into the structure …

As investigators plan the next round of genome-wide association studies (GWAS), cohorts of
more than 100 000 individuals are being proposed as the solution to the “missing …

Genome-wide association studies (GWAS) aim to identify common genetic variants that are
associated with traits and diseases. Since 2005, more than 5,000 GWAS have been …

The success of genome-wide association studies (GWAS) has significantly advanced our
understanding of the etiology of coronary artery disease (CAD) and opens new opportunities …

The past few years have seen significant advances in the identification of genetic factors that
contribute to complex disease. Progress in cardiovascular diseases (CVD) has been …

The spring of 2012 marked the fifth anniversary of the widespread appearance in the
biomedical literature of genome-wide association studies (GWAS) of diseases of adulthood …

Over the last decade, the application of genetics to cardiac risk has transitioned from single
gene assessment in rare mendelian disorders to more common complex phenotypes such …

Cardiovascular disease (CVD) is still the leading cause of death in all western world
countries and genetic predisposition in combination with traditional risk factors frequently …